VANTABIO logo

Vanta Bioscience Ltd

VANTABIO·BSE·
19.64 +0.00 (+0.00%)
Market Cap13.97 Cr
PE Ratio130.90
Volume1,500
Day High - Low19.64 - 19.64
52W High-Low25.85 - 14.71
This price may be out of date. Last traded ₹19.64 on 13 Aug 2026 (22 days ago). Not a live price.
DocStoX Score
1.6/10
Poor
Fair Value
Sign in to see
ROE
0.70%
Weak
P/E
130.90x
Expensive
Debt / Equity
1.80
High
Industry
Healthcare
Healthcare Technology
Overall View
Poor

Price performance

52W14.71
25.85
DocStoX take

Held back by growth (0.0).

DocStoX score

Low confidence
1.6
/10
Poor
Quality
Modest
ROE 0.7%
Valuation
Rich
P/E 130.9×
Growth
Flat
Revenue -28.6% 5Y CAGR
Risk
High risk
D/E 1.80
Momentum
Soft
44% of 52-week range

At a glance

Market Cap
₹14 Cr
52W High / Low
₹26 / ₹15
Dividend Yield
0.00%
Promoter Holding
72.81%
EPS (TTM)
₹0.15
Book Value
₹29.77

Key highlights

  • Healthy net margin (128%)
  • Profit shrinking 53% a year
  • Revenue shrinking 29% a year
1 Positive4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Healthcare Technology

Vanta Bioscience Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.